Suwon, South Korea

Young-Hwa Chun

This inventor holds 1 USPTO granted patent. Top assignee: Pinotbio, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young-Hwa Chun. Retrieved from https://idiyas.com/inventor/young-hwa-chun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young-Hwa Chun and Patent Activity in Biotechnology.

Introduction

Young-Hwa Chun is an inventor associated with Suwon, South Korea, and Pinotbio, Inc. The supplied information identifies her work in biotechnology and pharmaceutical research.

Latest Patents

Chun is credited with 1 patent: “Combined Therapy of 4'-Thio-5-Aza-2'-Deoxycytidine and Venetoclax.” The patent concerns a combination therapy involving the compounds named in its title.

Career Highlights

Chun’s listed patent activity connects her with Pinotbio, Inc., a company working in the biotechnology sector. The available information does not provide further details about her role or career history.

Collaborations

The supplied information lists Doo-Young Jung and Jin-Soo Lee as Chun’s coworkers. Their specific contributions to the patent are not provided.

Conclusion

Young-Hwa Chun’s recorded patent activity centers on a combination therapy involving 4'-thio-5-aza-2'-deoxycytidine and venetoclax, reflecting her association with biotechnology innovation at Pinotbio, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…